Current status of thrombolytics-the need for better, especially safer, agents. Thromb Res 2008;122 Suppl 3:S1-2
Date
08/20/2008Pubmed ID
18710780DOI
10.1016/j.thromres.2008.06.008Scopus ID
2-s2.0-50849135517 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
Clot dissolution using enzymes from the human fibrinolytic system has long been a goal of physicians and scientists. While recent focus has been on activators of the fibrinolytic system, new data support the use of plasmin itself. This supplement reviews the role of plasmin in fibrinolysis and locally administered plasmin as a safe and effective therapeutic.
Author List
White GC 2ndAuthor
Gilbert C. White MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Fibrinolytic AgentsHumans
Thrombosis